| 12280054 |
Treatment of hidradenitis suppurativa using JAK inhibitors |
Michael Howell |
2025-04-22 |
| 12268667 |
JAK1 pathway inhibitors for the treatment of prurigo nodularis |
Kurt Andrew Brown |
2025-04-08 |
| 12150943 |
JAK1 pathway inhibitors for the treatment of gastrointestinal disease |
Krishnaswamy Yeleswaram, Gregory F. Hollis |
2024-11-26 |
| 12005067 |
JAK inhibitor with a vitamin D analog for treatment of skin diseases |
Zheng ZHANG, Melissa Parker, James FIDGE |
2024-06-11 |
| 11992490 |
Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP) |
Jörg Wenzel |
2024-05-28 |
| 11957661 |
JAK1 pathway inhibitors for the treatment of vitiligo |
Kurt Andrew Brown, Michael Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos +1 more |
2024-04-16 |
| 11918581 |
Combination therapy comprising JAK pathway inhibitor and rock inhibitor |
Michael Peel |
2024-03-05 |
| 11596632 |
JAK1 pathway inhibitors for the treatment of gastrointestinal disease |
Krishnaswamy Yeleswaram, Gregory F. Hollis |
2023-03-07 |
| 11466324 |
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy |
Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more |
2022-10-11 |
| 11304949 |
Treatment of hidradenitis suppurativa using JAK inhibitors |
Michael Howell |
2022-04-19 |
| 10537566 |
Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis |
— |
2020-01-21 |
| 10208349 |
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy |
Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more |
2019-02-19 |